BIORESTORATIVE THERAPIES, INC. Interest and Dividend Income, Operating
BIORESTORATIVE THERAPIES, INC. (BRTX) reported Interest and Dividend Income, Operating of $6.06 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InterestAndDividendIncomeOperating · last filed 2026-05-14
- BIORESTORATIVE THERAPIES, INC. interest and dividend income, operating for the quarter ending 2026-03-31 was $6.06K, a 94.10% decline year-over-year.
- BIORESTORATIVE THERAPIES, INC. interest and dividend income, operating for the quarter ending 2025-12-31 was $34.70K, a 73.58% decline year-over-year.
- BIORESTORATIVE THERAPIES, INC. interest and dividend income, operating for the quarter ending 2025-09-30 was $59.34K, a 64.13% decline year-over-year.
- BIORESTORATIVE THERAPIES, INC. interest and dividend income, operating for the quarter ending 2025-06-30 was $73.74K, a 57.97% decline year-over-year.
- BIORESTORATIVE THERAPIES, INC. interest and dividend income, operating for fiscal 2025 was $270.57K, a 56.63% decline from fiscal 2024.
- BIORESTORATIVE THERAPIES, INC. interest and dividend income, operating for fiscal 2024 was $623.80K, a 9.62% increase from fiscal 2023.
- BIORESTORATIVE THERAPIES, INC. interest and dividend income, operating for fiscal 2023 was $569.07K, a 648.73% increase from fiscal 2022.
- BIORESTORATIVE THERAPIES, INC. interest and dividend income, operating for fiscal 2022 was $76.00K.
| Period end | Interest and Dividend Income, Operating 3 month | Interest and Dividend Income, Operating 6 month | Interest and Dividend Income, Operating 9 month | Interest and Dividend Income, Operating 12 month |
|---|---|---|---|---|
| 2026-03-31 | $6.06K 10-Q · filed 2026-05-14 | $40.76K derived: sum of 2 quarters · filed 2026-05-14 | $100.09K derived: sum of 3 quarters · filed 2026-05-14 | $173.84K derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-12-31 | $34.70K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $94.03K derived: sum of 2 quarters · filed 2026-03-26 | $167.77K derived: sum of 3 quarters · filed 2026-03-26 | $270.57K 10-K · filed 2026-03-26 |
| 2025-09-30 | $59.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $133.08K derived: sum of 2 quarters · filed 2025-11-12 | $235.88K 10-Q · filed 2025-11-12 | $367.20K derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-06-30 | $73.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $176.54K 10-Q · filed 2025-08-12 | $307.87K derived: sum of 3 quarters · filed 2026-05-14 | $473.28K derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-03-31 | $102.80K 10-Q · filed 2026-05-14 | $234.12K derived: sum of 2 quarters · filed 2026-05-14 | $399.54K derived: sum of 3 quarters · filed 2026-05-14 | $575.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $131.32K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $296.74K derived: sum of 2 quarters · filed 2026-03-26 | $472.20K derived: sum of 3 quarters · filed 2026-03-26 | $623.80K 10-K · filed 2026-03-26 |
| 2024-09-30 | $165.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $340.88K derived: sum of 2 quarters · filed 2025-11-12 | $492.48K 10-Q · filed 2025-11-12 | $894.68K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $175.47K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $327.06K 10-Q · filed 2025-08-12 | $729.27K derived: sum of 3 quarters · filed 2025-08-12 | $689.98K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $151.60K 10-Q · filed 2025-05-14 | $553.80K derived: sum of 2 quarters · filed 2025-05-14 | $514.51K derived: sum of 3 quarters · filed 2025-05-14 | $656.72K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $402.20K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $362.91K derived: sum of 2 quarters · filed 2025-03-28 | $505.13K derived: sum of 3 quarters · filed 2025-03-28 | $569.07K 10-K · filed 2025-03-28 |
| 2023-09-30 | -$39.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $102.93K derived: sum of 2 quarters · filed 2024-11-12 | $166.87K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $142.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $206.16K 10-Q · filed 2024-08-13 | ||
| 2023-03-31 | $63.94K 10-Q · filed 2024-06-11 | |||
| 2022-12-31 | $76.00K 10-K/A · filed 2024-06-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |